France winger set for medical as PSG reshape forward line under FFP pressure.
Liverpool have agreed a £123 million fee with Paris Saint-Germain for France winger Bradley Barcola, with a medical scheduled to complete one of the most expensive winger signings in Premier League history.
The 22-year-old is expected to undergo his medical in the coming days, with the formal announcement to follow shortly after. Personal terms are not considered an obstacle. Once registered, Barcola would become Liverpool's marquee attacking addition of the summer and a clear statement of intent from Arne Slot's side as the Premier League campaign gets under way.
Barcola rose through Lyon's academy and broke into the first team in Ligue 1 before completing a move to PSG, where he has won Ligue 1 titles and established himself as a senior France international. The French forward has been one of Ligue 1's most exciting wide players in recent seasons, drawing interest from several elite European clubs before Liverpool's move. He is comfortable across the front line, with pace and direct dribbling at the core of his game, and brings European experience from PSG's Champions League campaigns.
PSG have been open to a sale throughout the window as they reshape their forward line under Luis Enrique. The French club view Barcola's departure as creating significant room under Financial Fair Play limits, with younger attacking profiles already added this summer. Liverpool's offer of £123m meets the valuation and clears the way for the move. The proceeds from Barcola's sale would give PSG significant room to manoeuvre in the market.
The structure of the deal matters on both sides. PSG needed a clean sale to balance their books under FFP; Liverpool needed a marquee forward to elevate the attack. The £123m agreement, reported across multiple outlets, gives both clubs what they wanted on the headline numbers, with PSG clearing significant room on the balance sheet.
For Liverpool, Barcola offers elite pace, one-on-one quality and versatility across the front three. He can operate on either flank and brings a direct dribbling profile that complements the existing wide options. At 22, he is a long-term piece around whom the attack can be shaped for years to come.
The fee ranks among the biggest purchases in Liverpool's modern history. The club have been active elsewhere in the window — midfield and defensive additions have been confirmed — but a marquee attacker was the headline requirement. The £123m outlay underscores Liverpool's aggressive summer push to reinforce their attacking options.
Liverpool have not commented publicly on the negotiations while the move is uncompleted. PSG have similarly stayed quiet on the specific terms. The deal is not yet complete — a medical and formal announcement remain — though the broad terms are agreed across multiple sources.
Once the medical is complete, Barcola would be registered before the Premier League deadline and available for selection in the autumn fixtures, with the new season already under way. The move would add a high-ceiling attacker to Liverpool's squad ahead of the new season and significantly reshape the club's front line, with competition for wide places set to intensify.
Live scores, lineups and goal alerts for the teams in this story — get Socc360 for iOS.